- First Biotech 12-Pack: Oncology
- First module: CAR T cells
Published May 27, 2019
- Second module: Checkpoint inhibitors
Published September 18, 2019 - Subscription/contact form
- Download flier - B2C Iversity access
How does it work?Biotech 12 Packs are created and published much like a scientific
magazine. As a subscriber, you will receive new modules on a regular
basis, once every three to four weeks.
Each module contains a set of short video lectures (averaging 5 minutes)
and community resources: a discussion forum, a journal for taking notes
that can be shared, reference materials, announcements and short
quizzes to test your knowledge.
With each new module comes a set of Biotech toolboxes that introduce
relevant key terms, essential for mastering the common territory of all
biotechnology. These terms constitute a growing Biotech Toolboxes
Encyclopedia, a framework for the creation of shareable life sciences
knowledge for all stakeholders in healthcare.
As a subscriber you will get unlimited access to the content of all
Biotech Toolboxes that are part of your Biotech 12 pack subscription.
Content will be updated regularly, with a growing community of expert
contributors.
Target Audience:
- Non-scientists working in drug development
- Scientists working in drug development - Medical doctors in need of CME
- Investors - Regulatory Affairs professionals - Nurses and other caregivers - Patient advocates
- University students interested in life sciences
- Anyone with an interest in cancer therapies
About Iversity:
iversity.org is an online learning platform owned by the scientific publishing company Springer Nature.
It offers online courses in collaboration with universities, companies and institutions to support continual professional education. Today iversity.org has over 750,000 users and more than one million course enrolments.
Additional information: iversity.org
| 
